Cod-Liver Oil Improves Metabolic Indices and hs-CRP Levels in Gestational Diabetes Mellitus Patients: A Double-Blind Randomized Controlled Trial
Objective. To investigate the effects of cod-liver oil on metabolic status and high-sensitivity C-reactive protein (hs-CRP) in patients with gestational diabetes mellitus (GDM). Methods. This study was a randomized, double-blinded, placebo-controlled trial with the allocation ratio of 1 : 1. The con...
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2019-01-01
|
| Series: | Journal of Diabetes Research |
| Online Access: | http://dx.doi.org/10.1155/2019/7074042 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850179257815269376 |
|---|---|
| author | Shuli Yang Ruixin Lin Lihui Si Zhuo Li Wenwen Jian Qing Yu Yan Jia |
| author_facet | Shuli Yang Ruixin Lin Lihui Si Zhuo Li Wenwen Jian Qing Yu Yan Jia |
| author_sort | Shuli Yang |
| collection | DOAJ |
| description | Objective. To investigate the effects of cod-liver oil on metabolic status and high-sensitivity C-reactive protein (hs-CRP) in patients with gestational diabetes mellitus (GDM). Methods. This study was a randomized, double-blinded, placebo-controlled trial with the allocation ratio of 1 : 1. The contents of EPA and DHA in cod-liver oil were measured using a gas chromatograph. A total of 550 GDM patients were randomly divided into the intervention group (cod-liver oil) and the control group (placebo, mineral oil), and both groups were given regular dietary care. Glycosylated hemoglobin A1c (HbA1c), fasting plasma glucose (FPG), 2-hour plasma glucose (2hPG), lipid profiles, homeostatic model assessment insulin resistance (HOMA-IR), and hs-CRP were measured. Primary outcomes were different in HbA1c, FPG, 2hPG, and HOMA-IR between the two groups after 4-week randomization. Secondary outcomes were the blood glucose levels and perinatal complications (pregnancy-induced hypertension, polyhydramnios, premature delivery, postpartum hemorrhage, postpartum infection, premature rupture of membranes, and cesarean section) between the two groups before and after 12-16 weeks of cod-liver oil intervention from middle pregnancy to late pregnancy. Results. EPA and DHA were the main components of cod-liver oil with 76 mg/mL and 150 mg/mL, respectively. There was no significant difference for primary outcomes in the levels of HbA1c, FPG, 2hPG, HOMA-IR, and lipid profiles between the two groups (P>0.05). For the secondary outcomes, the levels of HbA1c, FPG, 2hPG, triglyceride (TG), total cholesterol (TC), low-density lipoprotein cholesterol ratio (LDL-C), HOMA-IR, and hs-CRP in the intervention group were significantly lower than those in the control group (P<0.05). The incidence of perinatal complications in the intervention group was lower than that in the control group too (P<0.05). Conclusions. Cod-liver oil consumption effectively reduced the levels of blood glucose, lipid levels, hs-CRP, and HOMA-IR and the incidence of perinatal complications. |
| format | Article |
| id | doaj-art-9f26f075ed8943c58b1a79b60c839df3 |
| institution | OA Journals |
| issn | 2314-6745 2314-6753 |
| language | English |
| publishDate | 2019-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Journal of Diabetes Research |
| spelling | doaj-art-9f26f075ed8943c58b1a79b60c839df32025-08-20T02:18:33ZengWileyJournal of Diabetes Research2314-67452314-67532019-01-01201910.1155/2019/70740427074042Cod-Liver Oil Improves Metabolic Indices and hs-CRP Levels in Gestational Diabetes Mellitus Patients: A Double-Blind Randomized Controlled TrialShuli Yang0Ruixin Lin1Lihui Si2Zhuo Li3Wenwen Jian4Qing Yu5Yan Jia6Department of Gynecology and Obstetrics, The Second Hospital of Jilin University, Changchun 130041, ChinaDepartment of Hepatopancreatobiliary Surgery, The Second Hospital of Jilin University, Changchun 130041, ChinaDepartment of Gynecology and Obstetrics, The Second Hospital of Jilin University, Changchun 130041, ChinaDepartment of Gynecology and Obstetrics, The Second Hospital of Jilin University, Changchun 130041, ChinaDepartment of Gynecology and Obstetrics, The Second Hospital of Jilin University, Changchun 130041, ChinaDepartment of Gynecology and Obstetrics, The Second Hospital of Jilin University, Changchun 130041, ChinaDepartment of Gynecology and Obstetrics, The Second Hospital of Jilin University, Changchun 130041, ChinaObjective. To investigate the effects of cod-liver oil on metabolic status and high-sensitivity C-reactive protein (hs-CRP) in patients with gestational diabetes mellitus (GDM). Methods. This study was a randomized, double-blinded, placebo-controlled trial with the allocation ratio of 1 : 1. The contents of EPA and DHA in cod-liver oil were measured using a gas chromatograph. A total of 550 GDM patients were randomly divided into the intervention group (cod-liver oil) and the control group (placebo, mineral oil), and both groups were given regular dietary care. Glycosylated hemoglobin A1c (HbA1c), fasting plasma glucose (FPG), 2-hour plasma glucose (2hPG), lipid profiles, homeostatic model assessment insulin resistance (HOMA-IR), and hs-CRP were measured. Primary outcomes were different in HbA1c, FPG, 2hPG, and HOMA-IR between the two groups after 4-week randomization. Secondary outcomes were the blood glucose levels and perinatal complications (pregnancy-induced hypertension, polyhydramnios, premature delivery, postpartum hemorrhage, postpartum infection, premature rupture of membranes, and cesarean section) between the two groups before and after 12-16 weeks of cod-liver oil intervention from middle pregnancy to late pregnancy. Results. EPA and DHA were the main components of cod-liver oil with 76 mg/mL and 150 mg/mL, respectively. There was no significant difference for primary outcomes in the levels of HbA1c, FPG, 2hPG, HOMA-IR, and lipid profiles between the two groups (P>0.05). For the secondary outcomes, the levels of HbA1c, FPG, 2hPG, triglyceride (TG), total cholesterol (TC), low-density lipoprotein cholesterol ratio (LDL-C), HOMA-IR, and hs-CRP in the intervention group were significantly lower than those in the control group (P<0.05). The incidence of perinatal complications in the intervention group was lower than that in the control group too (P<0.05). Conclusions. Cod-liver oil consumption effectively reduced the levels of blood glucose, lipid levels, hs-CRP, and HOMA-IR and the incidence of perinatal complications.http://dx.doi.org/10.1155/2019/7074042 |
| spellingShingle | Shuli Yang Ruixin Lin Lihui Si Zhuo Li Wenwen Jian Qing Yu Yan Jia Cod-Liver Oil Improves Metabolic Indices and hs-CRP Levels in Gestational Diabetes Mellitus Patients: A Double-Blind Randomized Controlled Trial Journal of Diabetes Research |
| title | Cod-Liver Oil Improves Metabolic Indices and hs-CRP Levels in Gestational Diabetes Mellitus Patients: A Double-Blind Randomized Controlled Trial |
| title_full | Cod-Liver Oil Improves Metabolic Indices and hs-CRP Levels in Gestational Diabetes Mellitus Patients: A Double-Blind Randomized Controlled Trial |
| title_fullStr | Cod-Liver Oil Improves Metabolic Indices and hs-CRP Levels in Gestational Diabetes Mellitus Patients: A Double-Blind Randomized Controlled Trial |
| title_full_unstemmed | Cod-Liver Oil Improves Metabolic Indices and hs-CRP Levels in Gestational Diabetes Mellitus Patients: A Double-Blind Randomized Controlled Trial |
| title_short | Cod-Liver Oil Improves Metabolic Indices and hs-CRP Levels in Gestational Diabetes Mellitus Patients: A Double-Blind Randomized Controlled Trial |
| title_sort | cod liver oil improves metabolic indices and hs crp levels in gestational diabetes mellitus patients a double blind randomized controlled trial |
| url | http://dx.doi.org/10.1155/2019/7074042 |
| work_keys_str_mv | AT shuliyang codliveroilimprovesmetabolicindicesandhscrplevelsingestationaldiabetesmellituspatientsadoubleblindrandomizedcontrolledtrial AT ruixinlin codliveroilimprovesmetabolicindicesandhscrplevelsingestationaldiabetesmellituspatientsadoubleblindrandomizedcontrolledtrial AT lihuisi codliveroilimprovesmetabolicindicesandhscrplevelsingestationaldiabetesmellituspatientsadoubleblindrandomizedcontrolledtrial AT zhuoli codliveroilimprovesmetabolicindicesandhscrplevelsingestationaldiabetesmellituspatientsadoubleblindrandomizedcontrolledtrial AT wenwenjian codliveroilimprovesmetabolicindicesandhscrplevelsingestationaldiabetesmellituspatientsadoubleblindrandomizedcontrolledtrial AT qingyu codliveroilimprovesmetabolicindicesandhscrplevelsingestationaldiabetesmellituspatientsadoubleblindrandomizedcontrolledtrial AT yanjia codliveroilimprovesmetabolicindicesandhscrplevelsingestationaldiabetesmellituspatientsadoubleblindrandomizedcontrolledtrial |